Kaleido Biosciences, Inc.
KLDODelisted Apr 18, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001751299
Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Kaleido Biosciences, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 71
- 0 vs. Q1 2021
- Shares held
- 34.7M
- +344.5K (+1.0%) vs. Q1 2021
- Total value
- $257.8M
- −$20.1M (−7.2%) vs. Q1 2021
- New holders
- 13
- 29 more added
- Sold out
- 13
- 10 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KLDO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 3 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 3 | $0 |
| Q1 2025 | 2 | $2 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 3 | $31.0K |
| Q1 2022 | 63 | $55.1M |
| Q4 2021 | 66 | $80.8M |
| Q3 2021 | 71 | $189.6M |
| Q2 2021 | 71 | $257.8M |
| Q1 2021 | 71 | $277.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Kaleido Biosciences, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Toth Financial Advisory Corp | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 68 | $1.00K | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 100 | $1.00K | 0.00% | −30−23.1% | Reduced |
| Salem Investment Counselors Inc | 125 | $1.00K | 0.00% | +125 | New |
| Advisory Services Network, LLC | 90 | $1.00K | 0.00% | +90 | New |
| Cutler Group LP | 400 | $2.00K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 250 | $2.00K | 0.00% | 00.0% | Unchanged |
| Carroll Financial Associates, Inc. | 339 | $2.00K | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 265 | $2.00K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 332 | $2.47K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 500 | $4.00K | 0.00% | −2,112−80.9% | Reduced |
| Captrust Financial Advisors | 598 | $4.00K | 0.00% | +598 | New |
| Wells Fargo & Company | 611 | $5.00K | 0.00% | −518−45.9% | Reduced |
| Endurance Wealth Management, Inc. | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 749 | $5.00K | 0.00% | +749 | New |
| Laurel Wealth Advisors LLC | 625 | $5.00K | 0.00% | +625 | New |
| BNP Paribas Arbitrage, SA | 787 | $5.86K | 0.00% | −1,012−56.3% | Reduced |
| Johnson Midwest Financial, LLC | 745 | $6.00K | 0.01% | 00.0% | Unchanged |
| US Bancorp | 1,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 995 | $7.00K | 0.00% | 00.0% | Unchanged |
| Penserra Capital Management LLC | 970 | $7.00K | 0.00% | +30+3.2% | Added |
| Federation des caisses Desjardins du Quebec | 1,230 | $9.15K | 0.00% | +400+48.2% | Added |
| Legal & General Group Plc | 1,885 | $14.0K | 0.00% | +480+34.2% | Added |
| Royal Bank of Canada | 2,102 | $15.0K | 0.00% | +71+3.5% | Added |
| State of Wyoming | 2,112 | $16.0K | 0.01% | +2,112 | New |
| Citigroup Inc | 3,561 | $26.0K | 0.00% | +1,668+88.1% | Added |
| Barclays PLC | 3,798 | $28.0K | 0.00% | −7,799−67.3% | Reduced |
| Advisor Group Holdings, Inc. | 3,753 | $28.0K | 0.00% | +3,753 | New |
| Tower Research Capital LLC (TRC) | 4,015 | $30.0K | 0.00% | −2,297−36.4% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,610 | $42.0K | 0.00% | +100+1.8% | Added |
| New York State Common Retirement Fund | 9,004 | $67.0K | 0.00% | +104+1.2% | Added |
| JPMorgan Chase & Co | 9,548 | $71.0K | 0.00% | +4,136+76.4% | Added |
| Texas Yale Capital Corp. | 10,000 | $74.0K | 0.00% | +10,000 | New |
| D. E. Shaw & Co., Inc. | 10,483 | $78.0K | 0.00% | +10,483 | New |
| American International Group, Inc. | 10,854 | $81.0K | 0.00% | +2,893+36.3% | Added |
| Rhumbline Advisers | 10,842 | $81.0K | 0.00% | +10,842 | New |
| Deutsche Bank AG | 12,587 | $94.0K | 0.00% | +3,968+46.0% | Added |
| ProShare Advisors LLC | 12,665 | $94.0K | 0.00% | +12,665 | New |
| Alliancebernstein L.P. | 14,600 | $109.0K | 0.00% | +1,600+12.3% | Added |
| Bank of America Corp | 14,755 | $110.0K | 0.00% | +3,364+29.5% | Added |
| Goldman Sachs Group Inc | 18,220 | $136.0K | 0.00% | +2,837+18.4% | Added |
| Cerity Partners LLC | 18,800 | $140.0K | 0.00% | +300+1.6% | Added |
| Price T Rowe Associates Inc | 19,356 | $144.0K | 0.00% | −3,571−15.6% | Reduced |
| IHT Wealth Management, LLC | 19,320 | $144.0K | 0.01% | +19,320 | New |
| Exane Derivatives | 21,333 | $156.6K | 0.04% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 22,895 | $170.0K | 0.00% | −14,558−38.9% | Reduced |
| California State Teachers Retirement System | 26,753 | $199.0K | 0.00% | +6,150+29.9% | Added |
| Citadel Advisors LLC | 30,478 | $227.0K | 0.00% | +11,845+63.6% | Added |
| SG Americas Securities, LLC | 35,108 | $261.0K | 0.00% | +22,938+188.5% | Added |
| Morgan Stanley | 36,526 | $272.0K | 0.00% | +16,864+85.8% | Added |
| State of Wisconsin Investment Board | 41,800 | $311.0K | 0.00% | +1,800+4.5% | Added |
| Two Sigma Advisers, LP | 46,000 | $342.0K | 0.00% | −51,100−52.6% | Reduced |
| Bank of New York Mellon Corp | 50,528 | $376.0K | 0.00% | +5,069+11.2% | Added |
| First Trust Advisors LP | 55,056 | $410.0K | 0.00% | −259−0.5% | Reduced |
| Nuveen Asset Management, LLC | 78,840 | $586.0K | 0.00% | +13,900+21.4% | Added |
| Parametric Portfolio Associates LLC | 105,910 | $788.0K | 0.00% | +105,910 | New |
| Charles Schwab Investment Management Inc | 140,478 | $1.05M | 0.00% | +14,566+11.6% | Added |
| Trustees of Columbia University in the City of New York | 150,150 | $1.12M | 1.65% | 00.0% | Unchanged |
| Northern Trust Corp | 209,576 | $1.56M | 0.00% | +7,841+3.9% | Added |
| Geode Capital Management, LLC | 339,305 | $2.52M | 0.00% | +72,001+26.9% | Added |
| State Street Corp | 375,907 | $2.80M | 0.00% | +175,243+87.3% | Added |
| Artal Group S.A. | 500,500 | $3.72M | 0.08% | 00.0% | Unchanged |
| Baillie Gifford & Co | 658,461 | $4.90M | 0.00% | +1,070+0.2% | Added |
| Palo Alto Investors LP | 786,400 | $5.85M | 0.32% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 825,000 | $6.14M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,027,455 | $7.64M | 0.00% | +41,286+4.2% | Added |
| BlackRock Inc. | 1,075,022 | $8.00M | 0.00% | +64,659+6.4% | Added |
| HarbourVest Partners LLC | 1,833,832 | $13.6M | 1.30% | 00.0% | Unchanged |
| FMR LLC | 6,377,797 | $47.5M | 0.00% | +7,779+0.1% | Added |
| Flagship Pioneering Inc. | 19,575,710 | $145.6M | 1.86% | 00.0% | Unchanged |
| Raymond James & Associates | 0 | $0 | 0.00% | −101,550−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −54,100−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −37,074−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,665−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,669−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −12,356−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −468−100.0% | Sold out |
| Manchester Financial Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |